Quintrio
Home

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

QT Imaging Holdings, Inc. Common Stock

QTI

QT Imaging Holdings Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low frequency sound waves. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The company offers two products: QT Breast Scanner and QTviewer.

Last trade $1.76
Day change -$0.04 (-2.22%)
Day range $1.71 – $2.00
Volume 38,715
Market cap $26M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$26.45M
Price / earnings
—
Price / book
9.98×
Price / sales
0.89×
EV / sales
1.14×
EV / EBITDA
-4.64×

Profitability

Earnings per share
-$1.10
Return on assets
-52.95%
Return on equity
-610.08%
Dividend yield
0%

Liquidity and leverage

Debt / equity
5.77×
Current ratio
2.78×
Quick ratio
1.65×
Cash ratio
0.8×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$14.12M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for QTI, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$7.34M$7.44M$6.53M$8.28M$4.19M$3.66M$2.8M$846.83K
Cost of revenue$4.31M$4.38M$3.86M$5.13M$2.39M$1.83M$986K$446.77K
Gross profit$3.03M$3.06M$2.67M$3.14M$1.8M$1.83M$1.81M$400.07K
Selling, general and administrative$3.75M$3.3M$3.3M$2.6M$2.52M$1.97M$2M$1.68M
Research and development$1.72M$1.62M$1.72M$1.24M$939K$901K$852K$774.16K
Total operating expenses$5.48M$4.92M$5.02M$3.84M$3.46M$2.87M$2.85M$2.45M
Operating income-$2.45M-$1.86M-$2.35M-$700.21K-$1.65M-$1.04M-$1.04M-$2.05M
Interest expense-$328K-$745K-$930K$0-$565K-$379K-$691K$0
Income before taxes-$297K-$11.07M-$3.41M-$1.39M-$4.56M-$4M-$11.14M-$3.5M
Income taxes$0$2K$0-$3.78K$0$3K$0-$16K
Net income-$297K-$11.07M-$3.41M-$1.39M-$4.56M-$4M-$11.14M-$3.49M
Net income attributable to common shareholders-$297K-$11.07M-$3.41M-$1.39M-$4.56M-$4M-$11.14M-$3.49M
EBITDA-$2.39M-$1.84M-$2.33M-$684.69K-$1.61M-$1.01M-$1M-$2.05M
Basic earnings per share-$0.02-$0.75-$0.25-$0.10-$0.47-$0.42-$1.21$0.00
Diluted earnings per share-$0.02-$0.75-$0.25-$0.10-$0.47-$0.42-$1.21$0.00

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Vaso Gains More Than 65% in Three Months: What's Driving the Stock?

Vaso Corporation (VASO) has gained 65.1% over the past three months, significantly outperforming its industry peers and the broader market. The company's strong performance is driven by improved Q2 2026 results, higher revenues from professional sales services and medical equipment, and the completion of its exit from IT services through the sale of NetWolves. Following strategic divestitures, VASO is now focused on healthcare operations including GE HealthCare equipment representation and proprietary medical devices. While the company maintains financial flexibility and a clearer business focus, risks remain from its dependence on GE HealthCare and competitive pressures in regulated medical device markets.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.